Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Wagner

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Surgery|February 28, 2022
Nontumor related risk score: A new tool to improve prediction of prognosis after hepatectomy for colorectal liver metastasesKazunari Sasaki, Georgios Antonios Margonis, Amika Moro, et al.
JCO Clinical Cancer Informatics|December 22, 2021
Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based ModelDimitris Bertsimas, Georgios Antonios Margonis, Yifei Huang, et al.
The British Journal of Surgery|May 20, 2022
KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutationsPim B Olthof, Stefan Buettner, Nikolaos Andreatos, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 2, 2021
Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scoresKazunari Sasaki, Johan Gagnière, Aurélien Dupré, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 6, 2021
Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?Neda Amini, Nikolaos Andreatos, Georgios Antonios Margonis, et al.
The British Journal of Surgery|July 25, 2024
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective studyGeorgios Antonios Margonis, Jaeyun Jane Wang, Thomas Boerner, et al.
Annals of Surgery|December 1, 2022
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical QuestionsGeorgios A Margonis, Thomas Boerner, Jean-Baptiste Bachet, et al.
JAMA Surgery|June 1, 2022
Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver MetastasesDimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Surgery|February 28, 2022
Nontumor related risk score: A new tool to improve prediction of prognosis after hepatectomy for colorectal liver metastasesKazunari Sasaki, Georgios Antonios Margonis, Amika Moro, et al.
JCO Clinical Cancer Informatics|December 22, 2021
Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based ModelDimitris Bertsimas, Georgios Antonios Margonis, Yifei Huang, et al.
The British Journal of Surgery|May 20, 2022
KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutationsPim B Olthof, Stefan Buettner, Nikolaos Andreatos, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 2, 2021
Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scoresKazunari Sasaki, Johan Gagnière, Aurélien Dupré, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 6, 2021
Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?Neda Amini, Nikolaos Andreatos, Georgios Antonios Margonis, et al.
The British Journal of Surgery|July 25, 2024
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective studyGeorgios Antonios Margonis, Jaeyun Jane Wang, Thomas Boerner, et al.
Annals of Surgery|December 1, 2022
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical QuestionsGeorgios A Margonis, Thomas Boerner, Jean-Baptiste Bachet, et al.
JAMA Surgery|June 1, 2022
Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver MetastasesDimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, et al.
Pageof 17